BridgeMD
New treatment option for Eating Disorders
Official title Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders
ClinicalTrials.gov ID: NCT06792071
What this study is testing
- What it's testing
- The goal of this experimental interventional study is to learn if the psychological treatment Radically Open Dialectical Behavior Therapy (RO-DBT), is feasible to conduct and provide positive effects for adolescents with eating disorders and emotional overcontrol. Participants will be those at risk for developing severe and enduring eating disorder symptoms, as they have not responded fully to previous treatment attempts.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 19
You may be able to join if
- Being 14-19 years old
- Primarily restrictive eating disorder symptoms that remain despite at least one previous treatment attempt.
- Problems related to maladaptive overcontrol
- Written informed consent (for minors, this includes consent from all caregivers and the minors themselves).
You likely can't join if
- Eating disorders symptoms in need of emergency care
- High risk for suicide
- An inability to respond to the questionnaires or participate in the skills class, e.g., due to lack of knowledge in Swedish.
The study team makes the final eligibility decision.
Where it's taking place
- Uppsala, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 19 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Uppsala, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.